Search

Search Constraints

You searched for: Author/Creator Abeykoon, Jithma P.

Search Results

1. Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia. Issue 8 (22nd May 2021)

2. Classical and non‐classical phenotypes of Erdheim–Chester disease: Correlating clinical, radiographic and genotypic findings. (26th August 2022)

3. Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment‐naïve patients with Waldenstrom macroglobulinemia. (8th August 2017)

4. Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia. (2nd August 2021)

5. Efficacy of BRAF‐Inhibitor Therapy in BRAFV600E‐Mutated Adult Langerhans Cell Histiocytosis. (12th October 2020)

6. Efficacy of daratumumab‐based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials. Issue 11 (8th September 2017)

7. Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes. (29th August 2019)

8. Impact of belantamab mafodotin‐induced ocular toxicity on outcomes of patients with advanced multiple myeloma. (13th June 2022)

9. Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia. Issue 3 (31st December 2019)

10. Implications of detecting serum monoclonal protein by MASS‐fix following stem cell transplantation in multiple myeloma. (20th November 2020)